| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regenxbio Inc. (RGNX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. RGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $4.50M | - | |
| CEO | 342.5K | $3.11M | - | |
| Other | 247.9K | $2.25M | - | |
| Other | 215.4K | $1.95M | - | |
| Other | 82.2K | $745.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2018 | Vasista Vittal79 | Chief Financial Officer | Sell | 5,000 | $30.00 | $150,000.00 | -3.1% | |
| Mar 20, 2018 | Mills Kenneth T.81 | President And CEO | Sell | 10,000 | $29.55 | $295,500.00 | -4.2% | |
| Mar 13, 2018 | Simpson Curran66 | SVP, Technical Operations | Sale+OE | 25,000 | $33.00 | $825,000.00 | -38.8% | |
| Feb 28, 2018 | Vasista Vittal79 | Chief Financial Officer | Sell | 5,000 | $30.00 | $150,000.00 | -4.7% | |
| Feb 20, 2018 | Mills Kenneth T.81 | President And CEO | Sell | 10,000 | $26.56 | $265,600.00 | -4.0% | |
| Jan 22, 2018 | Mills Kenneth T.81 | President And CEO | Sell | 10,000 | $27.33 | $273,300.00 | -3.9% | |
| Jan 16, 2018 | Vasista Vittal79 | Chief Financial Officer | Sell | 5,000 | $30.16 | $150,800.00 | -4.5% | |
| Dec 22, 2017 | Simpson Curran66 | SVP, Technical Operations | Sale+OE | 30,000 | $33.03 | $990,900.00 | -43.2% | |
| Dec 20, 2017 | Mills Kenneth T.81 | President And CEO | Sell | 10,000 | $31.75 | $317,500.00 | -8.4% | |
| Dec 19, 2017 | Vasista Vittal79 | Chief Financial Officer | Sell | 5,000 | $30.00 | $150,000.00 | -2.9% |